PharmaCyte Biotech (PMCB) Preferred Stock Liabilities (2011 - 2026)
PharmaCyte Biotech's Preferred Stock Liabilities came in at $1.89 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with $1,000 a year earlier and up 49.0% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Preferred Stock Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Preferred Stock Liabilities was $1.27 million.
- Preferred Stock Liabilities carries a three-year compound annual growth rate of 982.6% (FY2023 to FY2026).
- Going back by fiscal year, Preferred Stock Liabilities was $2,000 in FY2025 (-100.0%), $11.87 million in FY2024 and $1,000 in FY2023.
- The fiscal Q1 2027 figure represents the highest quarterly Preferred Stock Liabilities since fiscal Q1 2025.
- Business Quant data shows PMCB's Preferred Stock Liabilities at $1.27 million (Q4 2026), $872,323 (Q3 2026) and $901,996 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | 1.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.89 Mn |
| Apr 30, 2026 | 1.27 Mn |
| Jan 31, 2026 | 872,323.00 |
| Oct 31, 2025 | 901,996.00 |
| Jul 31, 2025 | 1,000.00 |
| Apr 30, 2025 | 2,000.00 |
| Jan 31, 2025 | 1,000.00 |
| Oct 31, 2024 | 1,000.00 |
| Jul 31, 2024 | 5.33 Mn |
| Apr 30, 2024 | 11.87 Mn |
| Jan 31, 2024 | 17.52 Mn |
| Oct 31, 2023 | 21.30 Mn |
| Jul 31, 2023 | 16.75 Mn |
| Apr 30, 2023 | 1,000.00 |
| Apr 30, 2011 | -80,000.00 |
API Access
PharmaCyte Biotech Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();